4568 J . Org. Chem., Vol. 67, No. 13, 2002
Kuligowski et al.
with a mixture of diethyl ether and water (40/20 mL), and the
etheral phase was washed with water (3 × 50 mL). The
aqueous phases were acidified (pH 2) and extracted with ethyl
acetate (3 × 80 mL). The ethyl acetate phases were dried over
Na2SO4 and concentrated under reduced pressure to give the
crude [2R(4S)]-2-[N-(tert-butoxy)carbonyl]-3-[(4-hydroxy)pent-
1-ynylsulfanyl]propionic acid (854 mg).
gave 332 mg (87%) of iodide 15: 1H NMR (400 MHz) δ 1.32
(d, 3 H, J ) 6.4 Hz), 1.41 (s, 9 H), 1.91 (m, 1 H), 2.73 (m, 1 H),
3.12 (m, 1 H), 3.39 (dd, 1 H, J ) 14.8, 3.6 Hz), 4.59 (ddd, 1 H,
J ) 14.8, 3.6, 2.8 Hz), 5.02 (m, 1H), 5.37 (d, 1 H, J ) 7.6 Hz),
6.86 (t, 1H, J ) 8.4 Hz); 13C NMR (50.3 MHz) δ 19.9 (CH3),
28.3 (3CH3), 40.2 (CH2), 43.2 (CH2), 52.5 (CH), 68.8 (CH), 80.3
(C), 92.2 (C), 150.4 (CH), 154.7 (C), 168.5 (C); IR (CCl4) ν 3450,
1743, 1710, 1490, 1210, 1162, 1046 cm-1; MS (CI, NH3) m/z
414 (MH+). Anal. Calcd for C13H20O4NSI: C, 37.78; H, 4.88;
N, 3.39. Found: C, 38.03; H, 4.93; N, 3.19. [R]D +121 (c 0.93,
MeOH).
To a solution of triphenylphosphine (978 mg, 3.73 mmol,
1.50 equiv) in THF (255 mL) at reflux was added, over a period
of 12 h, a solution of the crude hydroxy acid obtained above
(765 mg, 2.49 mmol) and diethyl azodicarboxylate (590 mL,
3.73 mmol, 1.55 equiv) in THF (25 mL). The reflux was
maintained for an additional 12 h and then the solvent
removed under reduced pressure. The crude residue was
purified by chromatography on silica gel (9:1 cylohexane/ethyl
acetate) to give lactone 13 (351 mg, 50% yield) as a white solid.
Recrystallization in pentane-diethyl ether gave 274 mg of 13
as white crystals (39% yield): mp 117 °C; 1H NMR (400 MHz)
δ 1.45 (d, 3 H, J ) 6.4 Hz), 1.49 (s, 9 H), 2.46 (dd, 1 H, J )
16.1, 6.5 Hz), 2.52 (dd, 1 H, J ) 16.1, 8.95 Hz), 3.08 (dd, 1 H,
J ) 12.8, 5.9 Hz), 3.93 (dd, 1 H, J ) 12.8, 1.7 Hz), 4.87 (ddd,
1 H, J ) 7.3, 5.9, 1.7 Hz), 5.33 (ddq, 1 H, J ) 8.9, 6.5, 6.4 Hz),
5.41(d, 1H, J ) 7.3 Hz); 13C NMR (100.6 MHz) δ 20.0 (CH3),
28.3 (3 CH3), 29.1 (CH2), 40.3 (CH2), 52.7 (CH), 70.0 (CH), 77.0
(C), 80,3 (C), 97.3 (C), 155.1 (C), 171.9 (C); IR (CCl4) ν 3437,
(2E,5R,8R)-8-[N-(ter t-Bu toxy)ca r bon yl]-2-eth oxyca r bo-
n yl-5-m et h yl-4,5,8,9-t et r a h yd r o-7H -[1,6]-oxa t h ion in -7-
on e (16). To a solution of 15 (100 mg, 0.24 mmol), ethanol
(240 mL, 3.6 mmol), and triethylamine (510 mL, 3.6 mmol,
15 equiv), in acetonitrile (6 mL), was added PdCl2(PPh3)2 (34
mg, 0.2 equiv). The reaction mixture was stirred at 50 °C for
3 h under 8 bar of pressure of carbon monoxide. The solution
was then cooled and the solvent evaporated under reduced
pressure. Purification by flash chromatography on silica gel
of the crude residue (9:1 cyclohexane/ethyl acetate) gave 59
mg (67%) of lactone ester 16: 1H NMR (400 MHz) δ 1.30 (t,
3H, J ) 7.1 Hz), 1.43 (d, 3H, J ) 8.0 Hz), 1.45 (s, 9H), 2.38
(m, 1H), 3.00 (m, 1H), 3.04 (m, 1H), 3.36 (dd, 1H, J ) 14.9,
3.8 Hz), 4.23 (q, 2H, J ) 7.1 Hz), 4.48 (m, 1H), 5.10 (m, 1H),
5.42 (d, 1H, J ) 8.1 Hz), 7.47 (t, 1H, J ) 8.5 Hz); 1H NMR
(400 MHz, C6D6, 77 °C) δ 0.91 (d, 1H, J ) 6.5 Hz), 1.0 (t, 3H,
J ) 7.1 Hz), 1.38 (s, 9H), 1.78 (dd, 1H, J ) 12.5, 8.6 Hz), 2.60
(ddd, 1H, J ) 12.5, 8.6, 8.0 Hz), 2.90 (dd, J ) 14.9, 3.1 Hz,
1H), 3.37 (dd, J ) 14.9, 4.0 Hz, 2H), 4.02, 4.0 (2q, 2H, J ) 7.1
Hz), 4.52 (m, 1H), 4.74 (dq, 1H, J ) 8.0, 6.5 Hz), 5.23 (m, 1H),
7.25 (t, 1H, J ) 8.6 Hz); 13C NMR (100.6 MHz) δ 14.1 (CH3),
20.4 (CH3), 28.2 (3CH3), 37.7 (CH2), 41.6 (CH2), 53.2 (CH), 62.0
(CH2), 68.8 (CH), 80.2 (C), 130.1 (C), 149.0 (CH), 154.8 (C),
164.8 (C), 169.4 (C); IR (CCl4) ν 3455, 2984, 2937, 1750, 1710,
1611, 1494, 1370, 1259, 1162, 1067, 1042 cm-1; MS (CI, NH3)
m/z 360 (MH+). Anal. Calcd for C16H25O6NS: C, 53.46; H, 7.01;
N, 3.90. Found: C, 53.28; H, 7.24; N, 3.78. [R]D +12.5 (c 0.72,
MeOH).
2184, 1740, 1731, 1713, 1638, 1490, 1293, 1145, 1060 cm-1
;
MS (CI, NH3) m/z 303 (M + NH4+), 286 (MH+), 247, 230, 212,
202, 186, 158. Anal. Calcd for C13H19O4NS: C, 54.72; H, 6.71;
N, 4.91. Found: C, 54.64; H, 6.70; N, 4.93. [R]D +127.6 (c 1.76,
MeOH).
(2E,5R,8R)-8-[N-(ter t-Bu toxy)ca r bon yl]-2-tr ibu tylsta n -
n yl-5-m et h yl-4,5,8,9-t et r a h yd r o-7H -[1,6]-oxa t h ion in -7-
on e (14). To a solution of lactone 13 (235 mg, 0.82 mmol) in
toluene (1.5 mL) was added a suspension of Pd(PPh3)4 (190
mg, 0.17 mmol, 0.2 equiv) in toluene (5 mL) via cannula.
Bu3SnH (270 mL, 0.99 mmol, 1.2 equiv) was then slowly added
to the reaction mixture. After the mixture was stirred for 45
min at 20 °C, the solvent was removed under vacuum at 20
°C. The crude residue was purified by chromatography on silica
gel (92:8 cyclohexane/ethyl acetate) to give tin compound 14
(380 mg, 80% yield) as a colorless oil: 1H NMR (400 MHz) δ
0.89 (t, 9 H, J ) 7.3 Hz), 0.97 (t, 6 H, J ) 8.2 Hz), 1.31 (sext,
6 H, J ) 7.3 Hz), 1.37 (d, 3H, J ) 6.4 Hz),1.45 (s, 9H), 1.49 (tt,
6H, J ) 8.2, 7.3 Hz), 2.13 (ddd, 1 H, J ) 11.7, 7.8, 6.1 Hz),
2.89 (dd, 1 H, J ) 14.3, 3.5 Hz), 3.00 (ddd, 1 H, J ) 11.7, 7.8,
6.1 Hz), 3.07 (dd, 1 H, J ) 14.3, 1.9 Hz), 4.47 (ddd, 1 H, J )
7.9, 3.5, 1.9 Hz), 5.01 (qd, 1 H, J ) 6.4, 6.1 Hz), 5.46 (d, 1 H,
(2E,5R,8R)-8-[N-(ter t-Bu toxy)ca r bon yl]-5-m eth yl-2-[(N-
p r op a r gyl)ca r b oxa m id e ]-4,5,8,9-t e t r a h yd r o-7H -[1,6]-
oxa th ion in -7-on e (17). To a solution of 15 (100 mg, 0.24
mmol), in acetonitrile (6 mL), were added PdCl2(PPh3)2 (38 mg,
0.054 mmol, 0.2 equiv) and propargylamine (249 mL, 3.6 mmol,
15 equiv). The reaction mixture was stirred at 50 °C for 3 h
under 8 bar of pressure of carbon monoxide. The solution was
then cooled and the solvent evaporated under reduced pres-
sure. Purification by flash chromatography on silica gel of the
crude residue (9:1 cyclohexane/ethyl acetate) gave 58 mg (65%)
of 17 as a white crystalline solid:1H NMR (400 MHz) δ 1.45
(m, 12H), 2.24 (t, 1H, J ) 2.4 Hz), 2.50 (m, 1H), 2.90 (m, 1H),
3.08 (m, 2H), 4.10 (m, 2H), 4.50 (m, 1H), 5.05 (m, 1H), 5.33
117
119
J ) 7.9 Hz), 6.25 (t, 1 H, J ) 7.8 Hz, J
) J
) 45.1
Sn-H
Sn-H
Hz); 13C NMR (100.6 MHz) δ 10.5 (3CH2, J 119Sn- ) 333.6
13
C
117
13
Hz, J
) 318.9 Hz), 13.6 (3 CH3), 20.2 (CH3), 27.3 (3
Sn-
C
119
13
117
13
CH2, J
C ) J
C ) 58.6 Hz), 28.2 (3 CH3), 28.9 (3 CH2,
Sn-
119 13 117
Sn-
119
13
117
13
13
Sn- C
J
C ) J
C ) 13.7 Hz), 37.7 (CH2 J
C ) J
Sn-
Sn-
Sn-
) 40.4 Hz), 42.4 (CH2), 53.4 (CH), 69.9 (CH), 79.9 (C), 142.8
(C), 148.2 (CH), 154.8 (C), 169.0 (C); IR (CCl4) ν 3462, 1743,
1716, 1491, 1457, 1391, 1366, 13308, 1166, 1056 cm-1; MS (CI,
NH3) for the 120Sn major isotope m/z 578 (MH+), 478, 308, 291,
232, 188. Anal. Calcd for C25H47O4NSSn: C, 52.10; H, 8.22;
N, 2.43. Found: C, 52.54; H, 8.53; N, 2.19. [R]D +33.3 (c 0.77,
MeOH).
(2E,5R,8R)-8-[N-(ter t-Bu toxy)ca r bon yl]-2-iod o-5-m eth -
yl-4,5,8,9-tetr a h yd r o-7H-[1,6]-oxa th ion in -7-on e (15). To a
solution of the stannyl compound 14 (530 mg, 0.92 mmol) in
dichloromethane (5 mL) at 0 °C was slowly added a solution
of iodine (245 mg, 0.97 mmol, 1.05 equiv) in dichloromethane
(13 mL). The resulting brown solution was stirred at 0 °C for
30 min and concentrated under reduced pressure. The crude
residue was taken up in diethyl ether (15 mL) and treated with
an aqueous KF solution (2 g/10 mL). After 3 h at 20 °C, the
mixture was filtered through a pad of Celite. The aqueous
phase was extracted with diethyl ether, and the combined
organic phases were washed with brine, dried over MgSO4,
filtered, and concentrated in vacuo. Purification by flash
chromatography on silica gel (9:1 cyclohexane/ethyl acetate)
1
(m, 1H), 7.28 (m, 1H), 7.51 (t, 1H, J ) 8.6 Hz); H NMR (400
MHz, C6D6, 77 °C) δ 0.93 (d, 1H, J ) 6.5 Hz), 1.39 (s, 9H),
1.85 (t, 1H, J ) 2.5 Hz), 1.94 (dd, 1H, J ) 11.0, 8.5 Hz), 2.41
(ddd, 1H, J ) 11.0, 8.5, 8.0 Hz), 2.63 (dd, 1H, J ) 14.2, 3.1
Hz), 2.75 (dd, 1H, J ) 14.2, 4.2 Hz), 3.86, 3.93 (2ddd, 2H, J )
17.5, 5.5, 2.5 Hz), 4.46 (m, 1H), 4.59 (dq, 1H, J ) 8.0, 6.6 Hz),
5.15 (m, 1H), 6.90 (m, 1H), 7.39 (t, 1H, J ) 8.5 Hz); 13C NMR
(100.6 MHz) δ 20.2 (CH3), 28.2 (3CH3), 29.8 (CH2), 37.0 (CH2),
41.8 (CH2), 53.3 (CH), 69.5 (CH), 71.8 (C), 79.2 (CH), 80.3 (C),
131.0 (C), 146.0 (CH), 154.8 (C), 163.5 (C), 168.9 (C); IR (CCl4)-
ν 3450, 3308, 1744, 1709, 1666, 1611, 1493, 1262, 1162 cm-1
;
MS (CI, NH3) m/z 369 (MH+). Anal. Calcd for C17H24O5N2S:
C, 55.42; H, 6.57; N, 7.60. Found: C, 55.31; H, 6.56; N, 7.53.
[R]D + 23.8 (c 0.42, MeOH).
Ack n ow led gm en t. Aventis Pharma Industry is
thanked for financial support and for a fellowship to
C.K.
J O0103120